CNS Pharmaceuticals
CNS is a pharmaceutical company that discovers and develops drugs for cancer treatment.
Business Model:
Revenue: $2
Employees: 2-10
Industries / Tags:
Detailed CNS Pharmaceuticals Information
Geographic Data
Address: 2100 West Loop South
City: Houston
State: TX
Zip: 77027
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$6M
Raised Total:$18M
Social
Metrics
5,149,162Website Global Rank
1,815Website Monthly Traffic
Twitter Followers
Description
CNS is a pharmaceutical company that discovers and develops drugs for cancer treatment.
Contact Phone:
+18009469185
Contact Email:
CNS Pharmaceuticals went public on 11/7/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/7/2019
IPO Valuation:
$54M
Ticker Symbol:
CNSP
IPO Price:
$4/share
Amount Raised:
$9M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
